These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 30827058)
1. Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps. Elsayed FA; Tops CMJ; Nielsen M; Ruano D; Vasen HFA; Morreau H; J Hes F; van Wezel T Mol Genet Genomic Med; 2019 Apr; 7(4):e00603. PubMed ID: 30827058 [TBL] [Abstract][Full Text] [Related]
2. POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East. Siraj AK; Bu R; Iqbal K; Parvathareddy SK; Masoodi T; Siraj N; Al-Rasheed M; Kong Y; Ahmed SO; Al-Obaisi KAS; Victoria IG; Arshad M; Al-Dayel F; Abduljabbar A; Ashari LH; Al-Kuraya KS Mol Genet Genomic Med; 2020 Aug; 8(8):e1368. PubMed ID: 32567205 [TBL] [Abstract][Full Text] [Related]
3. POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer. Esteban-Jurado C; Giménez-Zaragoza D; Muñoz J; Franch-Expósito S; Álvarez-Barona M; Ocaña T; Cuatrecasas M; Carballal S; López-Cerón M; Marti-Solano M; Díaz-Gay M; van Wezel T; Castells A; Bujanda L; Balmaña J; Gonzalo V; Llort G; Ruiz-Ponte C; Cubiella J; Balaguer F; Aligué R; Castellví-Bel S Oncotarget; 2017 Apr; 8(16):26732-26743. PubMed ID: 28423643 [TBL] [Abstract][Full Text] [Related]
4. POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Bellido F; Pineda M; Aiza G; Valdés-Mas R; Navarro M; Puente DA; Pons T; González S; Iglesias S; Darder E; Piñol V; Soto JL; Valencia A; Blanco I; Urioste M; Brunet J; Lázaro C; Capellá G; Puente XS; Valle L Genet Med; 2016 Apr; 18(4):325-32. PubMed ID: 26133394 [TBL] [Abstract][Full Text] [Related]
5. Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Elsayed FA; Kets CM; Ruano D; van den Akker B; Mensenkamp AR; Schrumpf M; Nielsen M; Wijnen JT; Tops CM; Ligtenberg MJ; Vasen HF; Hes FJ; Morreau H; van Wezel T Eur J Hum Genet; 2015 Aug; 23(8):1080-4. PubMed ID: 25370038 [TBL] [Abstract][Full Text] [Related]
6. Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1. Buchanan DD; Stewart JR; Clendenning M; Rosty C; Mahmood K; Pope BJ; Jenkins MA; Hopper JL; Southey MC; Macrae FA; Winship IM; Win AK Genet Med; 2018 Aug; 20(8):890-895. PubMed ID: 29120461 [TBL] [Abstract][Full Text] [Related]
7. POLD1 and POLE Gene Mutations in Jewish Cohorts of Early-Onset Colorectal Cancer and of Multiple Colorectal Adenomas. Rosner G; Gluck N; Carmi S; Bercovich D; Fliss-Issakov N; Ben-Yehoyada M; Aharon-Caspi S; Kellerman E; Strul H; Shibolet O; Kariv R Dis Colon Rectum; 2018 Sep; 61(9):1073-1079. PubMed ID: 30086056 [TBL] [Abstract][Full Text] [Related]
8. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Valle L; Hernández-Illán E; Bellido F; Aiza G; Castillejo A; Castillejo MI; Navarro M; Seguí N; Vargas G; Guarinos C; Juarez M; Sanjuán X; Iglesias S; Alenda C; Egoavil C; Segura Á; Juan MJ; Rodriguez-Soler M; Brunet J; González S; Jover R; Lázaro C; Capellá G; Pineda M; Soto JL; Blanco I Hum Mol Genet; 2014 Jul; 23(13):3506-12. PubMed ID: 24501277 [TBL] [Abstract][Full Text] [Related]
9. Solving the enigma of POLD1 p.V295M as a potential cause of increased cancer risk. Mur P; Magraner-Pardo L; García-Mulero S; Díez-Villanueva A; Del Valle J; Ezquerro E; Lázaro C; Capellá G; Moreno V; Sanz-Pamplona R; Pons T; Valle L Eur J Hum Genet; 2022 Apr; 30(4):485-489. PubMed ID: 34285382 [TBL] [Abstract][Full Text] [Related]
10. Role of POLE and POLD1 in familial cancer. Mur P; García-Mulero S; Del Valle J; Magraner-Pardo L; Vidal A; Pineda M; Cinnirella G; Martín-Ramos E; Pons T; López-Doriga A; Belhadj S; Feliubadaló L; Munoz-Torres PM; Navarro M; Grau E; Darder E; Llort G; Sanz J; Ramón Y Cajal T; Balmana J; Brunet J; Moreno V; Piulats JM; Matías-Guiu X; Sanz-Pamplona R; Aligué R; Capellá G; Lázaro C; Valle L Genet Med; 2020 Dec; 22(12):2089-2100. PubMed ID: 32792570 [TBL] [Abstract][Full Text] [Related]
11. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Palles C; Cazier JB; Howarth KM; Domingo E; Jones AM; Broderick P; Kemp Z; Spain SL; Guarino E; Salguero I; Sherborne A; Chubb D; Carvajal-Carmona LG; Ma Y; Kaur K; Dobbins S; Barclay E; Gorman M; Martin L; Kovac MB; Humphray S; ; ; Lucassen A; Holmes CC; Bentley D; Donnelly P; Taylor J; Petridis C; Roylance R; Sawyer EJ; Kerr DJ; Clark S; Grimes J; Kearsey SE; Thomas HJ; McVean G; Houlston RS; Tomlinson I Nat Genet; 2013 Feb; 45(2):136-44. PubMed ID: 23263490 [TBL] [Abstract][Full Text] [Related]
12. The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management. Palles C; Martin L; Domingo E; Chegwidden L; McGuire J; Cuthill V; Heitzer E; ; Kerr R; Kerr D; Kearsey S; Clark SK; Tomlinson I; Latchford A Fam Cancer; 2022 Apr; 21(2):197-209. PubMed ID: 33948826 [TBL] [Abstract][Full Text] [Related]
13. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Spier I; Holzapfel S; Altmüller J; Zhao B; Horpaopan S; Vogt S; Chen S; Morak M; Raeder S; Kayser K; Stienen D; Adam R; Nürnberg P; Plotz G; Holinski-Feder E; Lifton RP; Thiele H; Hoffmann P; Steinke V; Aretz S Int J Cancer; 2015 Jul; 137(2):320-31. PubMed ID: 25529843 [TBL] [Abstract][Full Text] [Related]
14. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. Chubb D; Broderick P; Frampton M; Kinnersley B; Sherborne A; Penegar S; Lloyd A; Ma YP; Dobbins SE; Houlston RS J Clin Oncol; 2015 Feb; 33(5):426-32. PubMed ID: 25559809 [TBL] [Abstract][Full Text] [Related]
15. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559 [TBL] [Abstract][Full Text] [Related]
16. Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers. Jansen AM; van Wezel T; van den Akker BE; Ventayol Garcia M; Ruano D; Tops CM; Wagner A; Letteboer TG; Gómez-García EB; Devilee P; Wijnen JT; Hes FJ; Morreau H Eur J Hum Genet; 2016 Jul; 24(7):1089-92. PubMed ID: 26648449 [TBL] [Abstract][Full Text] [Related]
18. High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation. Hühns M; Nürnberg S; Kandashwamy KK; Maletzki C; Bauer P; Prall F Mod Pathol; 2020 Jun; 33(6):1220-1231. PubMed ID: 31857678 [TBL] [Abstract][Full Text] [Related]
19. Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk prediction. Hamzaoui N; Alarcon F; Leulliot N; Guimbaud R; Buecher B; Colas C; Corsini C; Nuel G; Terris B; Laurent-Puig P; Chaussade S; Dhooge M; Madru C; Clauser E Genet Med; 2020 Sep; 22(9):1533-1541. PubMed ID: 32424176 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population. Yao J; Gong Y; Zhao W; Han Z; Guo S; Liu H; Peng X; Xiao W; Li Y; Dang S; Liu G; Li L; Huang T; Chen S; Song L Sci Rep; 2019 Oct; 9(1):15767. PubMed ID: 31673068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]